Definitive radiotherapy for nasopharyngeal carcinoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 29, Issue 6, 2006, Pages 622-627

  Mendenhall, William M ^a,b   Morris, Christopher G ^a   Hinerman, Russell W ^a   Malyapa, Robert S ^a   Amdur, Robert J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Carcinoma; Nasopharynx; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADOLESCENT; ADULT; AGED; BLINDNESS; BONE NECROSIS; BRAIN NECROSIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; CONTROLLED STUDY; CRANIAL NERVE PARALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPOPITUITARISM; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; METASTASIS; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NECK DISSECTION; OPTIC NERVE DISEASE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SCHOOL CHILD; SHORT TERM MEMORY; TREATMENT OUTCOME; TREATMENT PLANNING; VISUAL IMPAIRMENT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33845487562     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000248895.90193.7e     Document Type: Conference Paper

References (25)

1. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-1450.
2. Lee AW, Sze WM, Au JS, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107-1116.
3. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004;101:1584-1593.
4. Leung TW, Tung SY, Sze WK, et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck. 2005;27:555-565.
5. Corry J, Fisher R, Rischin D, et al. Relapse patterns in WHO 2/3 nasopharyngeal cancer: is there a difference between ethnic Asian vs. non-Asian patients? Int J Radiat Oncol Biol Phys. 2006;64:63-71.
6. Leung TW, Tung SY, Wong VY, et al. Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease. Cancer. 2005;104:1648-1655.
7. Yi JL, Gao L, Huang XD, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 2006;65:161-168.
8. Mendenhall WM, Riggs CE, Amdur RJ, et al. Altered fractionation and/or adjuvant chemotherapy in definitive irradiation of squamous cell carcinoma of the head and neck. Laryngoscope. 2003;113:546-551.
9. Teo PM, Leung SF, Chan AT, et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys. 2000;48:1311-1322.
10. Lee AW, Sze WM, Yau TK, et al. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiother Oncol. 2001;58:121-130.
11. Mendenhall WM, Villaret DB, Amdur RJ, et al. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2002;24:1012-1018.
12. Liauw SL, Mancuso AA, Amdur RJ. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol. 2006;24:1421-1427.
13. Monroe AT, Bhandare N, Morris CG, et al. Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys. 2005;61:856-864.
14. Bhandare N, Monroe AT, Morris CG, et al. Does altered fractionation influence risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys. 2005;62:1070-1077.
15. American Joint Committee on Cancer. AJCC Cancer Staging Manual-Pharynx (Including Base of Tongue, Soft Palate, and Uvula). 6th ed. New York: Springer; 2002:33-45.
16. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol. 2006;24:2618-2623.
17. Mendenhall WM, Million RR, Mancuso AA, et al. Nasopharynx. In: Million RR, Cassisi NJ, eds. Management of Head and Neck Cancer: A Multidisciplinary Approach. 2nd ed. Philadelphia: J.B. Lippincott Company; 1994:599-626.
18. Taylor JMG, Mendenhall WM, Lavey RS. Dose, time, and fraction size issues for late effects in head and neck cancers. Int J Radiat Oncol Biol Phys. 1991;22:3-11.
19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
20. SAS Institute Inc. SAS OnlineDoc®, Version 8. Cary, NC: SAS Institute Inc.; 1999.
21. Lawless JE. Statistical Models and Methods for Lifetime Data. New York: Wiley; 1982:457-481.
22. Cox DR. Regression models and life tables - Series B (Methodological). JR Stat Soc. 1972;34:187-220.
23. Baujat B, Audry H, Bourhis J, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys. 2006;64:47-56.
24. Kwong DL, Sham JS, Leung LH, et al. Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2006;64:374-381.
25. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.